Author

Stewart Turner 1

1 Arena Pharmaceuticals, Inc,San Diego,United States

EFFICACY AND SAFETY OF OLORINAB, A PERIPHERALLY ACTING, HIGHLY SELECTIVE, FULL AGONIST OF CANNABINOID RECEPTOR 2, FOR THE TREATMENT OF ABDOMINAL PAIN IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: RESULTS FROM A PHASE 2B RANDOMIZED STUDY

Brooks D Cash, Anthony J. Lembo, David C. Kunkel, Brett A. English, Beatriz Lindstrom, Sharon Skare, Charlie Liu, Stewart Turner, Fabio Cataldi, Saleem Desai, Donald Lipkis, Jan Tack, Lin Chang

Preclinical and Clinical Efficacy of Olorinab, a Peripherally Restricted, Highly Selective Full Agonist of the Cannabinoid Type 2 Receptor for the Management of Visceral Pain in Inflammatory Bowel Disease

Bruce Yacyshyn, Stuart M. Brierley, Beatriz Lindstrom, John Adams, Stewart Turner, Brett A. English, Kathe Stauber, Peter D.R. Higgins

Item 1 - 2 / 2
1